Ford Motor appears to be the only major U.S. automaker to report a year-over-year sales increase in November 2021. Preliminary data show an increase of 5.9% compared to November 2020. Retail share totaled an estimated 13.8% or 2.7 percentage points higher than a weak November 2020. During November, 29 % of Ford retail sales came from previously placed customer orders as the company struggles to manage the semiconductor crisis* that is affecting the entire industry. Initial industry wide data show a 6% y-o-y decline in November, which was better than in the previous two months, but volume fell to 1 million units and the annualized selling rate fell to under 13 million units, according to LMC.
As usual Ford Motor should consider changing its name to Ford Truck. Ford brand SUVs achieved record November retail sales on the success of new products. Sales increased 25.6% y-o-y to a total of 66,390 vehicles. The Bronco family had its highest combined sales since launch – totaling 19,773 SUVs, which to put it in perspective is less than the output of one assembly plant on an annual basis. Continue reading











Immunomedics CFO Charged with Insider Trading
The Securities and Exchange Commission today charged the former Chief Financial Officer of pharmaceutical company Immunomedics, Inc. and his former romantic partner with insider trading in the company’s stock.
Herewith the, err, lowlights from the SEC legal action: while serving as CFO of Immunomedics, Usama Malik learned that the FDA had permitted the company to halt a clinical trial for a breast cancer drug because the existing trial data provided compelling evidence that the drug was effective. Malik – who was subject to a trading “black-out” that prohibited him and anyone living in his household from purchasing Immunomedics stock – immediately told Lauren S. Wood, with whom he lived at the time, as well as three family members. Wood and two of the family members then bought Immunomedics stock, as did an account in the name of the third family member’s spouse. Continue reading →